BABA three-lens brief
Evidence-based stock research on BABA. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Underperforming SPY by 9.5pp over 30 days.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 9.5pp over 30 days.
- Analyst mean target $186.07 — 71% above current (39 analysts).
- Negative free cash flow last quarterly (-$82.64B).
BABA closed at $108.56 (-0.77%) as of 2026-09-11. Market cap: $269.84B. P/E (trailing) 24.7. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $186.07 — 71% above current (39 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 9.5pp over 30 days.. Last quarter: Revenue $268.95B, net income $10.54B, free cash flow -$82.64B.
Why three lenses on BABA, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BABAacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BABA" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BABA brief"></iframe>